{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:16:30Z","timestamp":1768742190988,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CounterACT Program, National Institutes of Health Office of the Director (NIH OD)"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"crossref","award":["NO1-NS-4-2359"],"award-info":[{"award-number":["NO1-NS-4-2359"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neuroscience.2012.11.005","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T17:00:45Z","timestamp":1352912445000},"page":"145-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus"],"prefix":"10.1016","volume":"231","author":[{"given":"W.","family":"Pouliot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shekh-Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Yagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.E.","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.11.005_b0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1167.2009.02297.x","article-title":"Nonconvulsive status epilepticus and coma","volume":"51","author":"Bauer","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WNP.0b013e318030e8cb","article-title":"Incorporating abbreviated EEGs in the initial workup of patients who present to the emergency room with mental status changes of unknown etiology","volume":"24","author":"Bautista","year":"2007","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-5618.2010.00828.x","article-title":"Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial","volume":"12","author":"Bersudsky","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid: second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.addr.2011.11.006","article-title":"Chemical properties of antiepileptic drugs (AEDs)","volume":"64","author":"Bialer","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0040","first-page":"117","article-title":"Refractory status epilepticus","volume":"11","author":"Bleck","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1535-7511.2009.01345.x","article-title":"Less common etiologies of status epilepticus","volume":"10","author":"Bleck","year":"2010","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"issue":"Suppl. 3","key":"10.1016\/j.neuroscience.2012.11.005_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1528-1157.43.s.3.9.x","article-title":"Is it status?","volume":"43","author":"Brenner","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-011-0097-2","article-title":"Treatment of neuroterrorism","volume":"9","author":"Busl","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0085","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"DeLorenzo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.pec.0000214594.78261.65","article-title":"Pediatric nerve agent poisoning: medical and operational considerations for emergency medical services in a large American city","volume":"22","author":"Foltin","year":"2006","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0095","first-page":"11","article-title":"Responsiveness of status epilepticus to treatment with diazepan decreases rapidly as seizure duration increases","volume":"3","author":"Goodkin","year":"2003","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ana.410440609","article-title":"Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus","volume":"44","author":"Hesdorffer","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11940-005-0018-y","article-title":"Nerve agent toxicity and treatment","volume":"7","author":"Holstege","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0115","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0120","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuropharm.2010.03.004","article-title":"Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid","volume":"58","author":"Kaufmann","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0125","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1152\/jn.91062.2008","article-title":"A simple quantitative method for analyzing electrographic status epilepticus in rats","volume":"101","author":"Lehmkuhle","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(89)90038-7","article-title":"Self-sustaining limbic status epilepticus induced by \u2018continuous\u2019 hippocampal stimulation: electrographic and behavioral characteristics","volume":"3","author":"Lothman","year":"1989","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0145","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1542\/peds.2005-2752","article-title":"The pediatrician and disaster preparedness","volume":"117","author":"Markenson","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1081\/DCT-120027895","article-title":"Effects of fosphenytoin on nerve agent-induced status epilepticus","volume":"27","author":"McDonough","year":"2004","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002040050637","article-title":"Comparative evaluation of benzodiazepines for control of soman-induced seizures","volume":"73","author":"McDonough","year":"1999","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1468-1331.2006.01397.x","article-title":"EFNS guideline on the management of status epilepticus","volume":"13","author":"Meierkord","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ncl.2004.12.013","article-title":"Nerve agents","volume":"23","author":"Newmark","year":"2005","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.nrl.0000252923.04894.53","article-title":"Nerve agents","volume":"13","author":"Newmark","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2004.10.003","article-title":"Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat","volume":"63","author":"Pitkanen","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0190","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.0013-9580.2004.01904.x","article-title":"Propofol treatment of refractory status epilepticus: a study of 31 episodes","volume":"45","author":"Rossetti","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0200","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1542\/peds.112.3.648","article-title":"Nerve agent attacks on children: diagnosis and management","volume":"112","author":"Rotenberg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0205","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1586\/ern.11.160","article-title":"Problems and controversies in status epilepticus: a review and recommendations","volume":"11","author":"Seif-Eddeine","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.106.111252","article-title":"Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine","volume":"320","author":"Shih","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0220","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/092986711794927720","article-title":"Comparison of status epilepticus models induced by pilocarpine and nerve agents - a systematic review of the underlying aetiology and adopted therapeutic approaches","volume":"18","author":"Tang","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/0748233706th268oa","article-title":"Development of a rat pilocarpine model of seizure\/status epilepticus that mimics chemical warfare nerve agent exposure","volume":"22","author":"Tetz","year":"2006","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.eplepsyres.2012.04.014","article-title":"Characterization of status epilepticus induced by two organophosphates in rats","volume":"101","author":"Todorovic","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0240","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.neuroscience.2012.11.005_b0245","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.eplepsyres.2005.07.020","article-title":"Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus","volume":"68","author":"Treiman","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2011.03338.x","article-title":"A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage","volume":"53","author":"White","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.11.005_b0255","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.clinph.2011.07.053","article-title":"Emergent EEG in the emergency department in patients with altered mental states","volume":"123","author":"Ziai","year":"2012","journal-title":"Clin Neurophysiol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212010913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212010913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:38:47Z","timestamp":1759678727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212010913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":51,"alternative-id":["S0306452212010913"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.11.005","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}